Statistical analysis Statistical analysis was performed using Gra

Statistical analysis Statistical analysis was performed using GraphPad Prism software 5. 0. Students t test was used to analyze the data. selleck Values of p 0. 05 or less were considered statistically significant. Results Induction of apoptosis by fungal taxol and baccatin III in Jurkat cells Interference of the mitotic spindle apparatus by microtubule stabilizing drugs would be expected to have an effect on the cell cycle distribution. To determine whether taxol and its precursor would have any such ef fect, JR4 Jurkat cells were treated for 48 h with 0. 1 uM fungal taxol and 3. 5 uM baccatin III, subjected to PI stain ing and the DNA content of the cells measured by flow cytometry. Flow cytometry analysis showed that while un treated and vehicle treated Jurkat cells were pre dominantly in the G1 phase of the cell cycle, significant changes were observed with fungal taxol and baccatin III treated cells.

Upon treatment, the percentage of G1 and G2/M cells decreased and the percentage of sub G1 cells increased considerably, suggesting initiation of apoptosis process in the cells. Induction of apoptosis by taxol and baccatin III in cells We observed a clear dose and time dependent induc tion of apoptosis by taxol and baccatin III in cells. The maximal increase in the frequency of apoptotic cells was observed after 48 h of incubation with 0. 1 uM fungal taxol, while the maximal induction of apoptosis by fungal baccatin III was obtained in 48 h at a concentration of 5 uM. Later the effect of induction of apoptosis by fungal taxol and baccatin III was analyzed in adherent cell lines.

HepG2, HeLa, Ovcar3 and T47D cells treated with fungal taxol and baccatin III showed results similar to that obtained with the Jurkat cells. Time and concentration dependent effect of fungal taxol and baccatin III on apoptosis induction in the four different adherent cell lines was observed, though the IC50 concentrations differed. IC50 values of apoptosis were calculated from all the five different cell lines that were in duced by fungal taxol and baccatin III. Both the compounds were active in all the cancer cell lines we tested, with IC50 ranging from 0. 005 to 0. 2 uM for fungal taxol and 2 5 uM for fungal baccatin III. These results indicate that both fungal taxol and baccatin III have potent apop tosis inducing activity.

Fungal taxol and baccatin III induced reduction of mitochondrial membrane potential in JR4 Jurkat cells Disturbance AV-951 in the mitochondrial membrane potential is an early event in the process of apoptosis and can be studied using the cationic carbocyanine dye JC 1 as a fluorescent marker for assessing the loss in mitochon drial membrane potential. The distinctive feature of JC 1 is its potential sensitive emission color shift resulting in a decrease of the red/green fluorescence intensity ratio in response to mitochondrial depolarization.

Related to this, our group and others have detected consistent ex

Related to this, our group and others have detected consistent ex pression http://www.selleckchem.com/products/dorsomorphin-2hcl.html of ER mRNA in MDA MB 231 cells. however, whether this expression may be related to membrane bound ER is actually unknown. More recently, Zhang and co workers indicated that 4OHT promoted the proliferation of ER negative breast cancer cells via the stimulation of the MAPK/ERK pathway, which is mediated by ER 36. Therefore, understand how 4OHT activates the MAPK cascade in ER negative breast cancer cells will require further studies. As a second approximation and to reduce the endogen ous levels of ER, we treated MDA MB 231 cells with fulvestrant. Fulvestrant is a potent anti oestrogen that pos sesses extremely high ER binding affinity and has two major effects on ER signalling.

First, it blocks ER sig nalling by inhibiting receptor dimerisation and nuclear localisation and, second, it blocks ER expression and ER mediated gene transcription. In addition, binding of fulvestrant to the ER has been proposed to induce proteasomal degradation of the aberrant receptor complex. As observed in Figure 2C, treatment with fulvestrant reduced the growth of cells treated with 4OHT. All to gether, these experiments support the notion that the effects of 4OHT on cell growth promotion in MDA MB 231 cells were dependent on an intact ER signalling. ER regulates E2F1 expression in ER negative breast cancer cells to mediate 4OHT resistance Recently, it has been proposed that ER regulates E2F1 expression to mediate tamoxifen resistance in ER positive cells.

The overexpression of E2F1 has been shown to be sufficient to promote breast cancer prolif eration by regulating the expression of cyclins and Cdks to mediate the G1 S transition. Although the E2F1 promoter lacks the classic oestrogen response elem ent 5 GGTCAnnnTGACC 3, ER is known to interact with several other transcription factors, including Sp1. In fact, it has been clearly demonstrated that tamoxifen increases ER/Sp1 interactions, modulating E2F1 expression in MCF7 tamoxifen resistant cells. Therefore, we performed a ChIP assay to deter mine whether 4OHT can promote the recruitment of ER to the E2F1 promoter. The results shown in Figure 3A indicated that compared to the control, 4OHT substantially increased the occupancy of ER on the E2F1 promoter. Consistent with the ChIP and proliferation data, semiquantitative RT PCR analysis indicated that the expression levels of E2F1 were markedly increased after exposure to 4OHT conditions. For these experiments, control cells and those subjected to 72 h of 4OHT treatment were GSK-3 harvested for gene expression analysis. Finally, to determine whether E2F1 con tributed to the increased proliferation after 4OHT exposure, we silenced E2F1 expression in MDA MB 231 cells using specific siRNAs.

The specificity of the fluorescent signal was determined by IETD

The specificity of the fluorescent signal was determined by IETD fmk and LEHD CHO, the specific inhibitors for the caspase selleck catalog 8 and caspase 9 respectively. Background The transcription of genes is highly regulated by epige netic chromatin modifications, including the acetylation of lysine residues protruding from nucleosomal histones. Thus, histone acetylation status is maintained by the opposing actions of histone acetyl transferase and histone deacetylase enzymes. HDACs modify gene expression via multiple mechanisms. The deacetylation of histones causes general chromosome condensation, and also plays a role in transcriptional regulation by forming a combinatorial histone code that regulates downstream responses. Additionally, a variety of non histone tar gets such as transcription factors, structural and chaper one proteins are targeted by HDAC enzymes.

The Zn2 dependent mammalian HDAC isoenzymes are divided into three classes based on their homology to yeast deacetylase proteins. Class I HDAC isoforms include HDAC1, 2 and 3 that are ubiquitously expressed as well as the low abundance HDAC8. Class II and IV isoforms display a more restricted tissue pattern of expression. A number of cofactors are required for HDAC activity. indeed, they reside in multi protein complexes including co regulators and other chromatin modifying enzymes. Recent advances into the biology of HDAC enzymes reveal a substantial division of labor between HDAC sub types. Modulating HDAC expression demonstrates that class I HDACs are essential for proliferation and sur vival.

Hence, HDAC1 and HDAC3 are believed to be important for proliferation, whereas HDAC2 is likely involved in the regulation of apoptosis. HDAC8 has been implicated in smooth muscle cell con tractility, though its knockdown also affects proliferation in tumor cells. Class II HDACs are mainly involved in cell differentiation and development, while selective HDAC6 inhibition by tubacin also induced cytotoxicity without accompanying gene expres sion changes. Aberrant expression of HDAC1, 2, 3 and 6 has been observed in various tumor types, and HDAC2 mutant mice display reduced tumor devel opment. Further, the transformed epigenome of neo plastic cells includes specific hypo acetylation of histone H4. Together, these findings provide the rationale for the targeted inhibition of HDAC enzymes.

HDACi treat ment increases global acetylation levels, which ultimately results in cell cycle arrest, apoptosis or terminal differenti ation of transformed cells. A considerable variation in the gene Batimastat expression response to HDACi depending on cell line and structural class of drug has been demonstrated, and because HDACi treatment potentially affects the entire transcriptome, it is interesting that pan HDAC inhi bition changes the expression of a relatively small percent age of genes.

1% BSA control for 18hrs After 18 hrs challenge, cells were spun

1% BSA control for 18hrs. After 18 hrs challenge, cells were spun down for RNA isolation and supernatants were removed for cytokine and chemokine measurements. Real time quantitative PCR Total RNA was isolated using QIAGEN RNeasy mini tubes selleck catalog according to the manufacturers animal cell extrac tion protocol which included the DNase step. All TAQMAN probes were purchased from Applied Biosystems. Reverse tran scription was performed in 100 ul of reaction solution using the following reagents per condition, 10 ul of 10X reverse transcrip tion buffer, 20 ul of 25 mM MgCl2, 10 ul of 10 mM dNTP mixture, 5 ul of 50 uM random hexamer, 5 ul of 20 U ul RNase inhibitor, 5 ul of 50 U ul Multiscribe reverse transcriptase and 45 ul of RNase free H2O RNA template mix.

The RT PCR reaction con ditions 10min incubation at 25 C, 30min at 42 C and 5min at 99 C. The real time PCR reaction was carried out using the Fast TAQMAN PCR apparatus and the following reagents were used per PCR condition which was carried out in a 20 ul volume, 10 ul of 2X master mix, 1 ul of 20X TAQMAN primer probe mix, 0. 2 ul of AmpErase Uracil N glycosylase, 0. 8 ul of sterile water and 8 ul of cDNA template. The amplification conditions were as follows, 2 min at 50 C, 20 sec at 95C, followed by 40 cycles of 95 C for 1 sec and 60 C for 20 sec. All expression data was normalized for loading using human PPIA. Cytokine and chemokine measurements Cells were cultured in the manner described above for siRNA knockdown studies. For studies using com pounds, cells were seeded as described above, but in the absence of siRNA transfection.

In this case, 1 day follow ing plating, cells were treated with Compound A, Sul phorfane, CDDO or DMSO. 1 hour after compound dosing, cells were challenged with 1 ng ml human IL 1B, or 10 ng ml human TNF R D systems, 210 TA or 10 ng ml mouse IL 13 or PBS 0. 1% BSA control for an additional 24 hrs. Cells were then spun down and super natants were assayed for cytokine and chemokine using Mesoscale Discovery platform assay plates according to manufacturers protocols. Statistical analysis Students t test was performed on all data points. All data are represented as mean Standard Deviation. Results siRNA knockdown of NRF2 and KEAP1 in NHLFs To better understand NRF2 KEAP1 regulated genes in the lung, we chose to employ siRNA knockdown in nor mal human lung fibroblasts to specifically modulate this pathway.

In this approach, we utilized knockdown of KEAP1, which should result in NRF2 acti vation, to identify those genes regulated by NRF2 activation and utilized knockdown of NRF2 to better de fine those genes dependent on baseline NRF2 activity. To minimize any confounding effects of potential off target activity of siRNA we conducted our study Dacomitinib using three distinct pools of siRNA for both KEAP1 and NRF2.

A non direct role of ERa in the cytoplasm has been proposed to pl

A non direct role of ERa in the cytoplasm has been proposed to play a role in acquired resistance to antiestrogens, in particular OHT. Indeed, in OHT resistant cells, the ERa accumulated in the cytoplasm, nilotinib mechanism of action suggesting that SERM stimulated ERa relocalization into the nucleus may be necessary for anti hormone effectiveness. An attractive possibility would thus reside in not only blocking indirect ERa functions which rely on MEK ERK and PI3K pathways in SERM resistant tumors, but to increase ERa translocation into the nucleus. The crystal structure of ERa bound to different ligands has revealed a spectrum of conformational states that involve the repositioning of helix H12 of the receptors ligand binding domain and formation the receptors cofactor associating surfaces.

It was proposed that the ligand binding cavity has a remarkable plasticity with a preferential binding mode for distal hydroxyl groups showing similar orientations for distal side chains in a or b positions of different ligands. RU39 and RU58 are derivatives of 17b estradiol but with different side chains. The shorter dimethyl amino ethoxy phenyl side chain is similar to the one in 4 hydroxytamoxifen and likely to be easily accommodated by the cavity. In contrast, RU58 has a bulky hydrophobic side chain similar to the one in fulvestrant which hampers the folding of helix 12. Thus the molecular structure of ERa ligands alone indicates the potential for SERM or SERD like activities of the compound. Interestingly, E2 induced focal accumulations of ERa scattered throughout the nucleus in the presence of E2 and of SERDs.

In agreement with this observation, numerous ERa rich domains of about 100 nm are detectable following E2 stimulation. It is well established that upon E2 addition, ERa binds to promoter of ERa target genes. Stimulated genes are found at numerous sites in the nucleus similarly to ERa protein. Thus, we propose that the observed ERa rich nuclear clusters correspond to association of the receptor with chromatin structures of ERa responsive Cilengitide genes and the proteasome to ensure its own turnover while tar get genes are being transcribed. Similarly, SERD bound ERa also concentrated into nuclear foci which frequently colocalize with the proteasome inde pendently of DNA binding. This may explain why ligand bound ERa is less dynamic, and appears more strongly associated with nuclear matrix like structures.

Quantitative real time polymerase chain reaction Messenger RNA ex

Quantitative real time polymerase chain reaction Messenger RNA expression level selleck chemicals Cisplatin for each HDAC was eval uated using an ABI 7500 machine. Amplifications were obtained using on demand TaqMan probes for each HDAC. For relative quantification of gene expression, standard curves were constructed for each gene by considering at least 3 points in triplicate of 10 fold serial dilution of cDNA in water, starting from 1 10 of a volume of undiluted cDNA transcribed from 1. 0 g of total RNA. The slopes of standard curves ranged from 3. 17 to 3. 87. Blank and standard controls were run in parallel to verify amplification efficiency within each experiment. To normalize differences in the amount of total cDNA added to each reaction, glucuro nidase gene expression was used as an endog enous control.

As a calibrator sample, the U343 cell line was used. To obtain the Ct values, we established a threshold of 0. 1. All reactions were made in duplicate, and all pro cedures were carried out at 4 C. Western Blotting For protein analysis, 30 g of each sample was loaded and separated by sodium dodecyl sulphate polyacrylamide gel electrophoresis. Proteins were transferred to nitrocel lulose membranes, and the membranes were then incu bated in 1% Tris buffered saline Tween 20 containing 5% dried non fat milk for 1 hour at room temperature. The primary antibodies were diluted at 1 3000 in TBST containing 5% milk HDAC9, Acetyl Lys H3, and Acetyl Lys H4, and the membranes were incubated for 1 hour at room temperature, The membranes were then washed 3 times with TBST, incubated with the secondary antibody labeled by horseradish perox idase for 1 hour at room tem perature, and washed 3 times with TBST.

The secondary antibody was visualized using electron chemiluminescent reagent. Films were exposed from 10 to 60 seconds and developed. Statistical analysis Comparison of gene expression between groups of tumor was performed by nonparametric testes Mann Whitney and Kruskall Wallis. The level of significance was set at p 0. 05 in all analyses. Results Global expression of HDAC genes in gliomas and normal brain tissue The expression of 12 HDAC genes was analyzed using rel ative quantification of mRNA levels in normal brain, astrocytomas grades I, II and III, and glioblastomas. Class I HDAC genes showed lower levels of expression compared to the other classes studied.

The highest values of expression for class I were seen for HDAC8. Expression of HDAC class II and class IV were higher, with values of approximately 1. 0 to 150. 0. The highest level of mRNA was observed for HDAC9a and HDAC9b, with relative expression reaching values above 100 for normal brain tissue and grade I astrocytomas. however, HDAC6 and HDAC7 showed lev els of expression comparable with Entinostat those of class I. Table 1 shows the median values for each HDAC gene in all groups analyzed.

The retrieval task deliberately focused on challenging gene norma

The retrieval task deliberately focused on challenging gene normalization examples. Not surprisingly, assessment of the retrieval task, which included reviewing the top 5 10 retrieved articles for relevance to the input gene symbol, uncovered the same U0126 MEK inhibitor issues described above with correct species identification and other normalization problems. This prompted the UAG to recommend either abandoning or reassessing the retrieval task to make it independent of the normali zation issues. Analysis of individual articles from three use cases To associate terms appearing in text with specific biolo gical entities is challenging to both biocurators and sys tems. There are cases where different genes share the same name, even within a same species, which is a ser ious problem because it affects the proper identification of the gene, and, in the end, impacts its annotation.

It also affects the retrieval of relevant documents about the gene, with the biocurator spending time discerning what articles are for which gene. The biocurator usually looks for contextual information to assist in disambigua tion, such as chromosomal location, identification of the organism bearing the gene, the mention of a synonym, and the mention of an encoded domain or its sequence length, and these same features could be used by the system to enable the user to manually select the correct unique identifier from a set of possibilities. In addition, there are multiple cases where the article introduces information for multiple genes and species, but the evi dence associating genes and species is outside the sen tence or paragraph containing curatable information.

Sometimes Methods sections or figure legends indicate species origins via information about cDNA constructs or cell lines. In other cases the information is found in a cited reference and or acknowledgments, but there are cases where the organism source information is simply not provided. Systems should provide whatever means necessary to help the biocurator relate gene mentions to the correct species. Another challenging use case is the introduction of a new gene name. The curator is then tasked with captur ing the new gene name, species and linking it to a s case it is expected that the system could link to the organism genome database if the gene is not yet annotated in multi species gene or protein databases, such as Entrez Gene or UniProt.

With these use cases in mind, the UAG assessed the system using a set of articles that represented the selected problematic cases for curation described above, Batimastat namely, gene name ambiguity, species ambiguity, or introduction of new gene names, with the main goal of assessing whether an interactive system could provide the necessary tools to assist in resolving these challen ging issues. These cases are described below.

Flow cytometry analysis showed no differ ences in the sub G1 peak

Flow cytometry analysis showed no differ ences in the sub G1 peak between the control cells and the ATG 5 knockdown cells selleck chemicals llc in the absence of GO treatment, however, following treatment with 10 mU ml GO, the sub G1 peak area was less in the ATG 5 knock down cells than it was in the controls. Taken together, these results indicate that autophagy induction by oxidative stress does not protect cells from death, and that oxidative stress induces autophagy dependent or autophagic cell death. Discussion The current study shows that overexpression of IRS 1 promotes cells growth, inhibits basal autophagy, reduces oxidative stress induced autophagy, and diminishes oxi dative stress mediated autophagy dependent cell death. We have provided evidence that ROS induces autophagy via inhibition of IRS 1 PI3K mTOR signaling.

We found that low levels of ROS promote cell prolif eration, while high levels induce cell death, in agreement with previous reports. We found that the flow cytometry sub G1 peak area increased in the DNA histogram, indicating that ROS induces apoptosis, and that GO generated ROS induced autophagy. Oxidative stress induced autophagy did not protect cells from death, inhibition of autophagy by knockdown of ATG 5 reduced cell death caused by oxidative stress. These data suggest that oxidative stress induces autophagy dependent or autophagic cell death. Autophagy has been proposed to kill the cells directly, and to participate in a lethal signaling event activating an apoptotic or necrotic death pathway.

Our data is consentient with other reports supporting the notion that autophagic cell death does occur, although it is often thought to be a misnomer. Indeed, there are numerous reports suggesting that autophagy is a sur vival mechanism that protects cells in response to envir onmental stresses. In human and mouse cells, deletion of autophagy related genes generally fails to confer pro tection against the induction of cell death by stressors, and rather accelerates cell death. Additionally, the observation that chemicals with the ability to inhibit autophagy significantly accelerate cellular necrosis fur ther supports the idea that autophagy acts primarily as a cytoprotective, rather than cytotoxic process. In summary, oxidative stress can cause necrotic, apoptotic, and autophagic cell death.

Our observation of reduced phosphorylation of p70 S6K, a major downstream effector of mTOR, in response to GO treatment indicates that oxidative stress reduces mTOR activity. Additionally, overexpression of IRS 1 attenuates the inhibitory effect of oxidative stress on mTOR p70 S6K signaling. These results Cilengitide suggest that overexpression of IRS 1 competes with the inhibitory signal mediated by oxidative stress on mTOR. Importantly, the oxidative stress mediated induction of autophagy was attenuated by overexpres sion of IRS 1.

Therefore, the inhi bition of TNF a and IL 1b showed the reductio

Therefore, the inhi bition of TNF a and IL 1b showed the reduction of pul monary injury kinase inhibitor Vandetanib in ALI induced by LPS in mice. In the present study, the concentrations of TNF a and IL 1b in BALF and the expression of NF B p65 in nucleus increased significantly after LPS administration, and reached their peak at 3 hours respectively. Pretreat ment of butyrate markedly reduced the concentrations of TNF a and IL 1b in BALF, and suppressed the expression of NF B p65 in nucleus. In addition, we also found that in ALI mice the elevated MPO activity, a specific granulocyte enzyme, was significantly reduced by butyrate pretreatment. Although neutrophils have beneficial actions in eradicating microbial infections, excessive neutrophil accumulation in lung contributes to the development of ALI.

The cytokines secreted by alveolar macrophages, such as TNF a and IL 1b, play a key role in neutrophil recruitment to the lung. There fore, the reduced neutrophils infiltration in lung by butyrate administration was partially due to its inhibi tory effect on cytokines production. In our study, we also found the reduced expression of NF B in cytoplasm due to the enhanced NF B nuclear translocation after LPS administration, which was mark edly inhibited by butyrate pretreatment. Previous study showed that butyrate pretreatment of a human colon cell line inhibited the TNF a induced nuclear translocation of the pro inflammatory transcrip tion factor NF B in part by preventing the complete degradation of I B a by reducing proteasome activity in the cell.

Moreover, butyrate decreased TNF produc tion and pro inflammatory cytokine mRNA expression by intestinal biopsies and lamina propria cells from Crohns disease patients, and abolished LPS induced expression of cytokines by peripheral blood mononuclear cells and transmigration of NF B from the cytoplasm to the nucleus. In the RAW 264. 7 murine macrophage cells stimulated by LPS, butyrate down regulated NO production and prevented the acti vation of NF B through the stabilization of I B a and I B b. These results observed in vitro suggested that the anti inflammatory effects of butyrate in ALI may primarily rely on inhibition of I B degradation, and consequently inhibiting the nuclear translocation of NF B and the production of cytokines regulated by NF B. Pulmonary edema is a life threatening condition that frequently leads to acute respiratory failure.

Injury to the alveolar epithelium can disrupt the integrity of the alveolar GSK-3 barrier or down regulate ion transport path ways, thus, reducing net alveolar fluid reabsorption and enhancing the extent of alveolar edema. Here we observed a significant reduction of pulmonary injury and edema in lungs of ALI mice treated by butyrate. Therefore, butyrate possessed the protective effect on ALI, which implied the clinical use of butyrate in future.

It is interesting to note that the overexpression of TSP1, whethe

It is interesting to note that the overexpression of TSP1, whether induced by TGFb and PDGF in normal fibroblasts or basally in SSc lesional dermal fibroblasts, was inhibited by the MEK/ ERK inhibitor. All these results indicate that, as an endogenous activator of TGFb, TSP1 contributes to the pathological contractile http://www.selleckchem.com/products/AP24534.html activity of SSc fibroblasts. Moreover, TSP1 may also potentially mediate responses to PDGF in the pathogenesis of SSc. Our results are consistent with a previous suggestion that constitutive overexpression of TSP1 in SSc fibroblasts depends on autocrine TGFb signalling. Lesional SSc dermal fibroblasts overexpress syndecan 4, CCN2 and TSP1. CCN2 is expressed by mesenchymal cells undergoing active tissue remodelling, and is characteristically overexpressed in connective tis sue pathologies such as fibrosis and cancer.

Heparan sulfate chains of syndecan 4 mediate response to growth and differentiation factors such as TGFb. Syndecan 4 also binds CCN and acts as a coreceptor for CCN2. Although the precise nature of the interac tions among syndecan 4, CCN2 and TSP1 is still unclear, our previous investigations found low expres sion of TSP1 in fibroblasts isolated from syndecan 4 or CCN2 mice. In our current study, TSP1 knockdown with siRNA did not alter expression of syn decan 4 and CCN2. Collectively, these results suggest expression of TSP1 in fibroblast culture is downstream of both syndecan 4 and CCN2. It has been reported that, in a mouse model of arthritis, injection of TSP1 blocking peptides for 16 days reduced joint infiltration and inflammation and CCN2 message and protein levels.

However, this reduced CCN2 could result indirectly due to the ability of TSP1 to activate latent TGFb. Alternatively, a mechanism involving activation of cell types other than fibroblasts might be involved. There fore, whether TSP1 directly affects CCN2 expression in vivo in SSc still needs to be investigated. We have previously shown that Drug_discovery the ras/MEK/ERK classical MAP kinase cascade is important for several features of fibrogenesis. For example, MEK/ERK med iates the induction of CCN2 expression in normal mesenchymal cells. In addition, MEK/ERK is required for a SMA stress fibre assembly, via a synde can 4 dependent mechanism. Moreover, the enhanced constitutive ERK activation in lesional SSc fibroblasts is due to an increase in syndecan 4 expres sion.

The MEK ERK pathway and HSPGs contri bute to the overexpression of profibrotic proteins and enhanced contractile forces in SSc dermal fibroblasts, and the procontractile signals from TGFb are integrated through syndecan selleck compound 4 and MEK/ERK. TGFb has long been hypothesised to be a major contributor to patho logical fibrotic diseases. In this investigation we showed that TSP1 mediated TGFb activation con tributes to the pathological contractile activity of SSc fibroblasts via an ERK dependent mechanism.